ZURICH, June 2 (Reuters) – Novartis NOVN.S is resuming business enterprise in Ukraine just after reviewing how secure it was to function in the place that Russia invaded in February, the Swiss drugmaker stated.
“Following studying existing basic safety protocols in the nation, and on guidance which we will frequently critique, we have begun to resume organization operations remotely to support the war-torn region restore some fundamental crucial small business procedures,” Novartis explained on its web site in a article dated June 1.
“The safety and stability of our persons continues to be our range one particular goal, and we will regularly overview the scenario and our organization functions in Ukraine.”
Novartis mentioned it condemned the war in Ukraine and has been providing humanitarian aid, fiscal donations and medication to people today there. Russia describes its invasion as a “special military procedure” to disarm and “de-Nazify” its neighbour.
(Reporting by Paul Arnold and Michael Shields Editing by Muralikumar Anantharaman)
The sights and thoughts expressed herein are the views and opinions of the writer and do not automatically reflect all those of Nasdaq, Inc.